Clinical Trials Logo

Clinical Trial Summary

In summary, there are currently many therapeutic tools for achieving some degree of control or even cessation of tobacco addictive use. No single therapy seems to have proven itself sufficiently effective to be the preferred treatment axis in the management of this addiction. We can also point out that so far the main treatments aimed at reducing or controlling the craving phenomenon are of a pharmacological nature, thus exposing the participants to the side effects inherent to this type of treatment. In this perspective, the establishment of non invasive brain stimulation (TdCS), acting in a targeted manner on craving and whose effects would be mild and transient, appears quite justified, especially in addition to psychotherapy. In the context of the management of addictive pathologies, the choice of smoking dependence seems relevant to us insofar as this addiction represents a major public health problem.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04209153
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact Florence THIBAUT, PHD
Phone (33) 1 58 41 16 79
Email florence.thibaut@aphp.fr
Status Recruiting
Phase
Start date November 29, 2021
Completion date May 29, 2025